Developer docs
API playgroundTry for free, no card

Search company profiles

Trially

Full company profile

uuid00002sl

Namestring
Trially
Legal namestring
Trially Inc.
Websiteurl
trially.ai
Company typeenum
Private
Founded yearint
2023
Descriptiontext

Trially is a Kansas City, Missouri-based AI-native software company founded in 2023 that sells a clinical-trial patient-recruitment platform to pharmaceutical sponsors, contract research organizations (CROs), clinical research sites, and hospital systems. The platform is composed of three integrated modules—Trially Match (LLM-powered patient-to-trial matching), Trially Connect (Margo AI agent for patient engagement, prescreening, scheduling, and outreach), and Trially Intelligence (feasibility analytics and pipeline radar)—that together claim ~95% pre-screening accuracy, a 73% reduction in screen failures, and a 91% reduction in manual EHR chart-review hours.

Under the hood, the platform uses LLM agents with a retrieval-augmented generation (RAG) architecture to synthesize both structured EHR fields (labs, vitals, medications, demographics) and unstructured clinical notes, imaging, and pathology reports, anchoring every eligibility decision to specific medical-record evidence. Native pre-built connectors link the platform to Epic, Oracle Cerner, NextGen, and AthenaHealth on the EHR side, and to CRIO, Salesforce, HubSpot, and Clinical Conductor on the CTMS/CRM side, enabling 1-day onboarding. Trially holds HIPAA, SOC 2 Type II, FDA 21 CFR Part 11, and ISO 27001 certifications, and its Margo agent carries generic IRB approval.

Trially operates an enterprise SaaS model with quote-based annual subscriptions sold primarily through direct field sales and channel partnerships such as the athenahealth Marketplace and CRIO CTMS integration. The company is venture-backed (a $4.7M seed round led by Flyover Capital closed in September 2025) and currently employs 1-10 people, with disclosed reference customers including CRIO, ClinTrial Research, and a 4-million-patient site network. Its stated objective is to compress clinical-trial enrollment timelines and reduce the $600,000+ daily cost of recruitment delays across the pharmaceutical industry.

Short descriptiontext

Trially is a Kansas City-based AI-native platform that uses LLMs to match, engage, and enroll patients into clinical trials at ~95% pre-screening accuracy. It sells subscription software to pharmaceutical sponsors, CROs, research sites, and hospitals, integrating natively with major EHR and CTMS systems.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersKansas City, United States
HQ citystring
Kansas City
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial recruitment, patient matching software, AI clinical trials, EHR patient identification, clinical research platform
Industry4 codes
PRIMARYHLAAANAI
Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials)
SECONDARYHLAGACAD
Clinical Trial Patient Recruitment & Retention
SECONDARYHLAAANAE
Clinical Decision Support & Workflow Integration (EHR/oncology systems)
SECONDARYHLAGACAH
Decentralized & Hybrid Trial Site Services (Home Health/Nursing)
NAICS code1 code
  • Scientific Research and Development Services5417
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Health Services8000
Product category
Clinical Trial Recruitment Software
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Platform Subscription
TypeSubscription Recurring
Description

SaaS subscription model for clinical trial recruitment platform. Pricing likely per site or per trial basis based on enterprise sales motion.

trially.ai
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise platform subscription
ModelSubscriptionBilling cadenceAnnual
Notes

Quote-based / Not publicly disclosed. Target buyers include enterprise sponsors, CROs, and site networks suggesting tiered or volume-based pricing.

trially.ai
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1Trially Match
Description

AI platform that safely reads rich medical data to instantly match patients to trials with ~95% accuracy.

trially.ai
+3 more records
Core offering1 text field

Trially is an AI-native SaaS platform that matches, engages, and enrolls patients into clinical trials by analyzing structured and unstructured EHR data. Its three integrated modules — Trially Match (LLM-based eligibility matching with ~95% accuracy), Trially Connect (Margo agentic AI for prescreening, scheduling, and multi-channel outreach), and Trially Intelligence (feasibility and pipeline analytics) — are sold to pharmaceutical sponsors, CROs, clinical research site networks, and hospitals via enterprise subscriptions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • 2-6x more patients enrolled per month in complex trials
+7 more records
Product overview1 text field

Trially is an AI-first clinical trial recruitment platform comprising three integrated modules: Trially Match (LLM-powered patient-to-trial matching with ~95% accuracy), Trially Connect (patient engagement via Margo AI agent), and Trially Intelligence (feasibility analytics and pipeline radar). The unified platform matches, engages, and enrolls qualified patients into clinical trials by analyzing structured and unstructured EHR data, automating prescreening, scheduling, and outreach workflows. The platform is designed for research sites, CROs, pharmaceutical sponsors, and hospitals, and integrates natively with major EHR systems (Epic, Cerner, NextGen, AthenaHealth) and CTMS platforms (CRIO).

Product and service4 records
1Trially Match
CategoryClinical Trial Patient Matching
Description

LLM-powered patient-to-trial matching module that instantly analyzes structured and unstructured EHR data to match patients against trial inclusion/exclusion criteria with approximately 95% accuracy, serving pharmaceutical sponsors, CROs, research sites, and hospitals.

2Trially Connect
CategoryClinical Trial Patient Engagement
Description

Patient engagement and enrollment module, powered by the Margo AI agent, that automates IRB-approved prescreening, multi-channel outreach (SMS, voice, email), appointment scheduling, and reminders to convert qualified patient matches into enrolled clinical trial participants.

3Trially Intelligence
CategoryClinical Trial Feasibility Analytics
Description

Feasibility analytics and pipeline radar module that provides real-time patient population analytics, exact patient counts for sponsors, and proactive alerts when trials match a site's patient population, enabling instant feasibility assessments before contracts are signed.

4Margo AI Agent
CategoryAgentic AI Patient Engagement
Description

Agentic AI that operates as a 'Super-Clinical Research Coordinator' within Trially Connect, autonomously handling IRB-approved prescreening, multi-channel outreach via SMS/voice/email, appointment scheduling, automated reminders, and re-engagement of dormant patient populations to convert matches into enrollments.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-13
Description

ClinTrial Research teamed up with Trially AI to multiply enrollment in complex clinical trials. Trially's proprietary AI improved their ability to pre-screen candidates, reducing time and resources spent on manual EHR chart reviews while improving diversity and quality of patient pools.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-01-29
Description

Trially joined athenahealth's Marketplace Program to enroll patients into clinical trials using their AI platform. This partnership enables athenahealth's healthcare provider customers to access Trially's AI-powered patient matching and recruitment capabilities directly through the athenahealth marketplace.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2024-09-03
Description

CRIO-Trially Integration enhances EMR workflows and patient identification. The integration combines Trially's AI matching software with CRIO's CTMS platform, enabling sites to quickly identify high-quality patients, focus recruitment strategy, and push patients through the CRM workflow without manual data entry.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Clinical trial patient matching and recruitment platform that integrates with EHRs to surface eligible patients for site networks. Direct overlap with Trially's site-network go-to-market.

2Deep 6 AI
TypeDirect peer
Description

AI-native patient recruitment and clinical trial matching platform that mines EHR data to identify eligible patients for trials. Directly comparable to Trially Match in product, buyer (sponsors and sites), and technology stack.

3Mendel
TypeDirect peer
Description

AI platform that structures unstructured clinical text and uses it for trial feasibility and cohort identification. Comparable to Trially's unstructured-EHR matching and feasibility analytics.

4Antidote (formerly Acurian)
TypeDirect peer
Description

Patient recruitment and engagement company for clinical trials, combining a patient-facing matching tool with site and sponsor services. Overlaps with Trially Connect's outreach and engagement scope.

TypeBroad incumbent
Description

Largest CRO with AI-driven patient recruitment (e.g., IQVIA's trial-matching and site-feasibility tools embedded in its broader R&D services stack). Competes for the same sponsor/CRO budget as Trially but as part of a much wider portfolio.

TypeBroad incumbent
Description

Clinical trial technology platform (Rave EDC, RTSM, eCOA, etc.) used by most large sponsors. Adjacent in trial operations and increasingly adding AI features that could overlap with Trially's recruitment wedge.

TypeBroad incumbent
Description

Cloud software provider for life sciences, including clinical operations (Veeva Vault CTMS, eTMF). Competes indirectly by serving the same pharma buyers with a broader enterprise suite.

TypeDirect peer
Description

Patient recruitment service for clinical trials using a curated patient community and outreach. Overlaps with Trially Connect's patient engagement and enrollment mission.

TypeDirect peer
Description

AI-powered clinical trial matching platform connecting patients, providers, and sponsors. Closely comparable in 'patient-to-trial matching' positioning and EHR integration approach.

TypeEmerging player
Description

AI-driven clinical trial enrollment company specializing in oncology, with patient concierge services. Comparable in patient-recruitment mission but narrower therapeutic focus.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration8 records

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors10 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Trially

Clinical Trial Recruitment Softwaretrially.ai

Trially is a Kansas City-based AI-native platform that uses LLMs to match, engage, and enroll patients into clinical trials at ~95% pre-screening accuracy. It sells subscription software to pharmaceutical sponsors, CROs, research sites, and hospitals, integrating natively with major EHR and CTMS systems.

What Trially does

Trially is a Kansas City, Missouri-based AI-native software company founded in 2023 that sells a clinical-trial patient-recruitment platform to pharmaceutical sponsors, contract research organizations (CROs), clinical research sites, and hospital systems. The platform is composed of three integrated modules—Trially Match (LLM-powered patient-to-trial matching), Trially Connect (Margo AI agent for patient engagement, prescreening, scheduling, and outreach), and Trially Intelligence (feasibility analytics and pipeline radar)—that together claim ~95% pre-screening accuracy, a 73% reduction in screen failures, and a 91% reduction in manual EHR chart-review hours.

Under the hood, the platform uses LLM agents with a retrieval-augmented generation (RAG) architecture to synthesize both structured EHR fields (labs, vitals, medications, demographics) and unstructured clinical notes, imaging, and pathology reports, anchoring every eligibility decision to specific medical-record evidence. Native pre-built connectors link the platform to Epic, Oracle Cerner, NextGen, and AthenaHealth on the EHR side, and to CRIO, Salesforce, HubSpot, and Clinical Conductor on the CTMS/CRM side, enabling 1-day onboarding. Trially holds HIPAA, SOC 2 Type II, FDA 21 CFR Part 11, and ISO 27001 certifications, and its Margo agent carries generic IRB approval.

Trially operates an enterprise SaaS model with quote-based annual subscriptions sold primarily through direct field sales and channel partnerships such as the athenahealth Marketplace and CRIO CTMS integration. The company is venture-backed (a $4.7M seed round led by Flyover Capital closed in September 2025) and currently employs 1-10 people, with disclosed reference customers including CRIO, ClinTrial Research, and a 4-million-patient site network. Its stated objective is to compress clinical-trial enrollment timelines and reduce the $600,000+ daily cost of recruitment delays across the pharmaceutical industry.

Trially firmographics

Firmographics
Name
Trially
Legal name
Trially Inc.
Website
https://trially.ai
Company type
Private
Founded year
2023
Operating status
Operating
Headcount range
11–50 employees
Short description
Trially is a Kansas City-based AI-native platform that uses LLMs to match, engage, and enroll patients into clinical trials at ~95% pre-screening accuracy. It sells subscription software to pharmaceutical sponsors, CROs, research sites, and hospitals, integrating natively with major EHR and CTMS systems.
Ownership category
akta.pro rank

Trially industry classification

Industry
Product category
Clinical Trial Recruitment Software
NAICS
Scientific Research and Development Services (5417)
SIC
Services-Prepackaged Software (7372), Services-Health Services (8000)
akta.pro industry
PRIMARYHLAAANAI
Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials)
SECONDARYHLAGACAD
Clinical Trial Patient Recruitment & Retention
SECONDARYHLAAANAE
Clinical Decision Support & Workflow Integration (EHR/oncology systems)
SECONDARYHLAGACAH
Decentralized & Hybrid Trial Site Services (Home Health/Nursing)

Keywords

  • Clinical trial recruitment
  • Patient matching software
  • AI clinical trials
  • EHR patient identification
  • Clinical research platform

Where Trially is headquartered

Location

Headquarters

HQ city
Kansas City
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Trially business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Platform Subscription: SaaS subscription model for clinical trial recruitment platform. Pricing likely per site or per trial basis based on enterprise sales motion.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise platform subscription

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Trially product offering

Product offering

Core offering

Trially is an AI-native SaaS platform that matches, engages, and enrolls patients into clinical trials by analyzing structured and unstructured EHR data. Its three integrated modules — Trially Match (LLM-based eligibility matching with ~95% accuracy), Trially Connect (Margo agentic AI for prescreening, scheduling, and multi-channel outreach), and Trially Intelligence (feasibility and pipeline analytics) — are sold to pharmaceutical sponsors, CROs, clinical research site networks, and hospitals via enterprise subscriptions.

Product overview

Trially is an AI-first clinical trial recruitment platform comprising three integrated modules: Trially Match (LLM-powered patient-to-trial matching with ~95% accuracy), Trially Connect (patient engagement via Margo AI agent), and Trially Intelligence (feasibility analytics and pipeline radar). The unified platform matches, engages, and enrolls qualified patients into clinical trials by analyzing structured and unstructured EHR data, automating prescreening, scheduling, and outreach workflows. The platform is designed for research sites, CROs, pharmaceutical sponsors, and hospitals, and integrates natively with major EHR systems (Epic, Cerner, NextGen, AthenaHealth) and CTMS platforms (CRIO).

Differentiator

Problem solved

Functional benefit

Brands

  • Trially Match: AI platform that safely reads rich medical data to instantly match patients to trials with ~95% accuracy.
  • Trially Connect
  • Trially Intelligence
  • Margo

Products and services

  • Trially Match LLM-powered patient-to-trial matching module that instantly analyzes structured and unstructured EHR data to match patients against trial inclusion/exclusion criteria with approximately 95% accuracy, serving pharmaceutical sponsors, CROs, research sites, and hospitals.
  • Trially Connect Patient engagement and enrollment module, powered by the Margo AI agent, that automates IRB-approved prescreening, multi-channel outreach (SMS, voice, email), appointment scheduling, and reminders to convert qualified patient matches into enrolled clinical trial participants.
  • Trially Intelligence Feasibility analytics and pipeline radar module that provides real-time patient population analytics, exact patient counts for sponsors, and proactive alerts when trials match a site's patient population, enabling instant feasibility assessments before contracts are signed.
  • Margo AI Agent Agentic AI that operates as a 'Super-Clinical Research Coordinator' within Trially Connect, autonomously handling IRB-approved prescreening, multi-channel outreach via SMS/voice/email, appointment scheduling, automated reminders, and re-engagement of dormant patient populations to convert matches into enrollments.

Quantifiable outcome

  • 2-6x more patients enrolled per month in complex trials
  • +7 more outcomes

Companies that use Trially

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Trially technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration8 records

AI capability8 records

Feature6 records

Trially partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • ClinTrial ResearchcoreStrategic or Co-development Partner · 13 May 2025ClinTrial Research teamed up with Trially AI to multiply enrollment in complex clinical trials. Trially's proprietary AI improved their ability to pre-screen candidates, reducing time and resources spent on manual EHR chart reviews while improving diversity and quality of patient pools.
  • athenahealthcoreTechnology or Integration · 29 January 2025Trially joined athenahealth's Marketplace Program to enroll patients into clinical trials using their AI platform. This partnership enables athenahealth's healthcare provider customers to access Trially's AI-powered patient matching and recruitment capabilities directly through the athenahealth marketplace.
  • CRIOcoreTechnology or Integration · 3 September 2024CRIO-Trially Integration enhances EMR workflows and patient identification. The integration combines Trially's AI matching software with CRIO's CTMS platform, enabling sites to quickly identify high-quality patients, focus recruitment strategy, and push patients through the CRM workflow without manual data entry.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Trially competitors and assessment

Company assessment

Direct peers

  • Trial Library: Clinical trial patient matching and recruitment platform that integrates with EHRs to surface eligible patients for site networks. Direct overlap with Trially's site-network go-to-market.
  • Deep 6 AI: AI-native patient recruitment and clinical trial matching platform that mines EHR data to identify eligible patients for trials. Directly comparable to Trially Match in product, buyer (sponsors and sites), and technology stack.
  • Mendel: AI platform that structures unstructured clinical text and uses it for trial feasibility and cohort identification. Comparable to Trially's unstructured-EHR matching and feasibility analytics.
  • Antidote (formerly Acurian): Patient recruitment and engagement company for clinical trials, combining a patient-facing matching tool with site and sponsor services. Overlaps with Trially Connect's outreach and engagement scope.
  • SubjectWell: Patient recruitment service for clinical trials using a curated patient community and outreach. Overlaps with Trially Connect's patient engagement and enrollment mission.
  • Carebox: AI-powered clinical trial matching platform connecting patients, providers, and sponsors. Closely comparable in 'patient-to-trial matching' positioning and EHR integration approach.

Broad incumbents

  • IQVIA (Orchard): Largest CRO with AI-driven patient recruitment (e.g., IQVIA's trial-matching and site-feasibility tools embedded in its broader R&D services stack). Competes for the same sponsor/CRO budget as Trially but as part of a much wider portfolio.
  • Medidata (Dassault Systèmes): Clinical trial technology platform (Rave EDC, RTSM, eCOA, etc.) used by most large sponsors. Adjacent in trial operations and increasingly adding AI features that could overlap with Trially's recruitment wedge.
  • Veeva Systems: Cloud software provider for life sciences, including clinical operations (Veeva Vault CTMS, eTMF). Competes indirectly by serving the same pharma buyers with a broader enterprise suite.

Emerging players

  • Massive Bio: AI-driven clinical trial enrollment company specializing in oncology, with patient concierge services. Comparable in patient-recruitment mission but narrower therapeutic focus.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Trially social profiles

Digital presence

Trially compliance and trust

Trust signal

Compliance4 records

Trially financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Trially leadership team

Management profile

Number of profiles

Profiles4 records

Trially funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Trially M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Trially

What does Trially do?

Trially is an AI-native SaaS platform that matches, engages, and enrolls patients into clinical trials by analyzing structured and unstructured EHR data. Its three integrated modules — Trially Match (LLM-based eligibility matching with ~95% accuracy), Trially Connect (Margo agentic AI for prescreening, scheduling, and multi-channel outreach), and Trially Intelligence (feasibility and pipeline analytics) — are sold to pharmaceutical sponsors, CROs, clinical research site networks, and hospitals via enterprise subscriptions.

Is Trially a public or private company?

Trially is a private company. It is classified as venture growth investor backed and is currently operating.

When was Trially founded?

Trially was founded in 2023. It employs 11 to 50 people.

Where is Trially based?

Trially is headquartered in Kansas City, United States, in the North America region.

How does Trially make money?

One revenue line is on record: platform Subscription.

Who are Trially's main competitors?

Direct peers on record are Trial Library, Deep 6 AI, Mendel, Antidote (formerly Acurian), SubjectWell and Carebox. Broad incumbents are IQVIA (Orchard), Medidata (Dassault Systèmes) and Veeva Systems. Massive Bio is listed as an emerging player.

Does Trially have an API?

No public API is recorded for Trially.

What industry is Trially in?

Trially's product category is Clinical Trial Recruitment Software. Its primary akta.pro industry code is HLAAANAI, Precision Clinical Trials Enablement (patient matching, site matching, adaptive trials), with a secondary code of HLAGACAD, Clinical Trial Patient Recruitment & Retention. Its NAICS code is 5417 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TriallyTrially AI Seed Round Secures $4.7M and Launches “Margo” to Solve Clinical Trial Recruitment Bottleneck - TriallyTrially AI raised $4.7 million in seed funding and launched Margo, an agentic AI tool to convert patient matches into trial enrollments. The platform claims ~95% screening accuracy and 73% fewer screen failures, with $4M revenue increase for one site network in three months. The company will use the funds to accelerate platform adoption across research sites and sponsors.PharmiWeb.comTrially AI Seed Round Secures $4.7M and Launches “Margo” to Solve Clinical Trial Recruitment BottleneckTrially AI raised $4.7 million in seed funding and launched Margo, an agentic AI platform for clinical trial recruitment. The platform claims ~95% screening accuracy and 73% fewer screen failures, with one site network seeing $4M revenue increase in three months. The company plans to accelerate adoption across research sites and sponsors.TmcnetTrially AI Joins athenahealth's Marketplace Program to Enroll Patients into Clinical Trials with Unprecedented Speed and PrecisionTrially AI announced an agreement with athenahealth to integrate its AI-driven clinical trial recruitment software into the athenahealth Marketplace. The integration reports a 2x increase in monthly patient enrollment, a 60% reduction in screen failure rates, and over 90% reduction in manual chart review hours. The software integrates with EHR systems and is available to over 160,000 providers.YahooTrially AI Joins athenahealth’s Marketplace Program to Enroll Patients into Clinical Trials with Unprecedented Speed and PrecisionTrially announced an agreement with athenahealth to integrate its AI-driven clinical trial recruitment software into the Marketplace program. The integration reports a 2x increase in monthly patient enrollment for complex weight loss studies, a 60% reduction in screen failure rates, and over 90% reduction in manual chart review hours.Business Wire BlogTrially AI Joins athenahealth’s Marketplace Program to Enroll Patients into Clinical Trials with Unprecedented Speed and PrecisionTrially announced an agreement with athenahealth to join its Marketplace program, integrating AI-driven clinical trial recruitment software. The software reports a 2x increase in monthly patient enrollment for a complex weight loss study, a 60% reduction in screen failures, and over 90% reduction in manual chart review hours.Business Wire BlogTrially AI Joins athenahealth’s Marketplace Program to Enroll Patients into Clinical Trials with Unprecedented Speed and PrecisionTrially announced an agreement with athenahealth to integrate its AI-driven clinical trial recruitment software into the athenahealth Marketplace. The software claims to double monthly patient enrollment in complex trials, cut screen failures from 52% to 20%, and reduce manual chart review hours from 36 to 2.5 monthly.American City Business JournalsTrially, Marma CEOs on addressing challenges in health careKyle and Meredith McAllister, a Kansas City couple, co-founded Trially and Marma to address clinical trial recruitment and women's health nutrition. Trially closed an oversubscribed preseed round and doubled to six employees, while Marma has 1,200 active users. Both startups are expanding, with Marma moving to a website and Trially adding staff.American City Business JournalsRedbud VC invests in Trially's AI platform for clincial trialsRedbud VC invested $120,000 in Kansas City startup Trially, which builds an AI platform to automate patient recruitment for clinical trials. The platform aims to address delays that cost $600,000 to $8 million daily, with a $2 billion market potential. Redbud expects the market to grow beyond that.